Clover Corp Valuation Multiples

Discover revenue and EBITDA valuation multiples for Clover Corp and similar public comparables like ArcticZymes, Darwin, American Vanguard, Fermentalg and more.

Clover Corp Overview

About Clover Corp

Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.


Founded

1988

HQ

Australia

Employees

68

Financials (LTM)

Revenue: $65M
EBITDA: $11M

EV

$93M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Clover Corp Financials

Clover Corp reported last 12-month revenue of $65M and EBITDA of $11M.

In the same LTM period, Clover Corp generated $11M in EBITDA and $7M in net income.

Revenue (LTM)


Clover Corp P&L

In the most recent fiscal year, Clover Corp reported revenue of $60M and EBITDA of $9M.

Clover Corp is profitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 14%, and net margin of 8%.

See analyst estimates for Clover Corp
LTMLast FY202320242025202620272028
Revenue$65M$60M$51M$50M$62M
Gross Profit-$18M$15M$14M$20M
Gross Margin-30%29%29%33%
EBITDA$11M$9M$5M$5M$10M
EBITDA Margin17%14%10%10%15%
EBIT Margin15%12%8%6%12%
Net Profit$7M$5M$3M$3M$6M
Net Margin10%8%6%5%9%

Financial data powered by Morningstar, Inc.

Clover Corp Stock Performance

Clover Corp has current market cap of $100M, and enterprise value of $93M.

Market Cap Evolution


Clover Corp's stock price is $0.60.

Clover Corp share price increased by 2.7% in the last 30 days, and by 56.3% in the last year.

Clover Corp has an EPS (earnings per share) of $0.03.

See more trading valuation data for Clover Corp
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$93M$100M-0.2%2.7%-14.1%56.3%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Clover Corp Valuation Multiples

Clover Corp trades at 1.4x EV/Revenue multiple, and 8.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Clover Corp

EV / Revenue (LTM)


Clover Corp Financial Valuation Multiples

As of July 19, 2026, Clover Corp has market cap of $100M and EV of $93M.

Clover Corp has a P/E ratio of 14.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.6x1.8x1.9x1.5x
EV/EBITDA8.6x10.9x17.8x18.0x9.8x
EV/EBIT9.5x13.2x23.5x29.0x12.4x
EV/Gross Profit-5.1x6.4x6.4x4.6x
P/E14.7x20.4x33.6x37.5x17.5x
EV/FCF(73.7x)19.3x24.2x20.7x42.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Clover Corp Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Clover Corp Margins & Growth Rates

Clover Corp grew revenue by 9% and EBITDA by 28% in the last fiscal year.

In the most recent fiscal year, Clover Corp reported gross margin of 30%, EBITDA margin of 14%, and net margin of 8%.

See estimated margins and future growth rates for Clover Corp

Clover Corp Margins

Last FY202420252026202720282029
Gross Margin30%29%33%36%
EBITDA Margin14%10%15%17%
EBIT Margin12%6%12%16%
Net Margin8%5%9%11%
FCF Margin8%9%4%2%

Clover Corp Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%(1%)24%15%
Gross Profit Growth29%(1%)41%25%
EBITDA Growth28%(1%)84%31%
EBIT Growth40%(19%)133%52%
Net Profit Growth40%(10%)115%39%
FCF Growth(130%)17%(51%)(31%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Clover Corp Operational KPIs

Clover Corp's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.

Clover Corp's Rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clover Corp's Rule of X is 56% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Clover Corp
LTMLast FY202320242025202620272028
Rule of 4040%33%---
Bessemer Rule of X75%56%---
Revenue per Employee-$0.9M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-6%7%7%6%
G&A Expenses to Revenue-9%8%9%9%
R&D Expenses to Revenue-3%4%4%3%
Opex to Revenue-21%21%22%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Clover Corp Competitors

Clover Corp competitors include ArcticZymes, Darwin, American Vanguard, Fermentalg, Cibus, Amoeba, Dyadic, Eden Research, Bioceres and Plant Advanced Technologies.

Most Clover Corp public comparables operate across Bioindustrials.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
ArcticZymes6.1x5.6x33.5x38.3x
Darwin0.5x0.5x4.0x(5.0x)
American Vanguard0.6x0.6x7.3x7.3x
Fermentalg4.3x3.5x(9.8x)(10.9x)
Cibus38.0x23.0x(1.7x)(1.7x)
Amoeba97.1x14.7x(11.0x)(16.0x)
Dyadic14.7x8.8x(6.6x)-
Eden Research5.1x4.2x(13.9x)(15.0x)

This data is available for Pro users. Sign up to see all Clover Corp competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Clover Corp

When was Clover Corp founded?Clover Corp was founded in 1988.
Where is Clover Corp headquartered?Clover Corp is headquartered in Australia.
How many employees does Clover Corp have?As of today, Clover Corp has over 68 employees.
Is Clover Corp publicly listed?Yes, Clover Corp is a public company listed on Australian Securities Exchange.
What is the stock symbol of Clover Corp?Clover Corp trades under CLV ticker.
When did Clover Corp go public?Clover Corp went public in 1999.
Who are competitors of Clover Corp?Clover Corp main competitors include ArcticZymes, Darwin, American Vanguard, Fermentalg, Cibus, Amoeba, Dyadic, Eden Research, Bioceres, Plant Advanced Technologies.
What is the current market cap of Clover Corp?Clover Corp's current market cap is $100M.
What is the current revenue of Clover Corp?Clover Corp's last 12 months revenue is $65M.
What is the current revenue growth of Clover Corp?Clover Corp revenue growth (NTM/LTM) is 23%.
What is the current EV/Revenue multiple of Clover Corp?Current revenue multiple of Clover Corp is 1.4x.
What is the current EBITDA of Clover Corp?Clover Corp's last 12 months EBITDA is $11M.
What is Clover Corp's EBITDA margin?Clover Corp's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of Clover Corp?Current EBITDA multiple of Clover Corp is 8.6x.
What is the current FCF of Clover Corp?Clover Corp's last 12 months FCF is ($1M).
What is Clover Corp's FCF margin?Clover Corp's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Clover Corp?Current FCF multiple of Clover Corp is (73.7x).
How many companies Clover Corp has acquired to date?Clover Corp hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Clover Corp has invested to date?Clover Corp hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Clover Corp

Lists including Clover Corp

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial